|
KCTD7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.677400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.443800E-02 |
| Normal-vs-Stage2 |
1.329800E-01 |
| Normal-vs-Stage3 |
5.032400E-01 |
| Normal-vs-Stage4 |
8.779600E-01 |
| Stage1-vs-Stage2 |
2.581400E-01 |
| Stage1-vs-Stage3 |
1.125840E-01 |
| Stage1-vs-Stage4 |
4.772400E-01 |
| Stage2-vs-Stage3 |
6.923800E-02 |
| Stage2-vs-Stage4 |
1.555780E-01 |
| Stage3-vs-Stage4 |
7.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.077200E-03 |
| Normal-vs-AfricanAmerican |
4.020800E-01 |
| Normal-vs-Asian |
9.509600E-01 |
| Caucasian-vs-AfricanAmerican |
2.058600E-01 |
| Caucasian-vs-Asian |
4.968400E-01 |
| AfricanAmerican-vs-Asian |
8.289600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.279600E-02 |
| Normal-vs-Female |
3.275300E-03 |
| Male-vs-Female |
6.502000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.216400E-01 |
| Normal-vs-Extreme_Weight |
1.914600E-01 |
| Normal-vs-Obese |
3.565800E-02 |
| Normal-vs-Extreme_Obese |
9.005000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.399800E-01 |
| Normal_Weight-vs-Obese |
1.384590E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.817200E-01 |
| Extreme_Weight-vs-Obese |
3.671400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.442000E-01 |
| Obese-vs-Extreme_Obese |
3.788200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.444400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.156100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.382770E-01 |
| Normal-vs-Age(81-100Yrs) |
5.459200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.129400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.950400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.061400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.366300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.914200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.365720E-04 |
| Normal-VS-Type2 PRCC |
4.746400E-01 |
| Normal-VS-KIRP CIMP |
1.344990E-01 |
| Normal-VS-Unclassified PRCC |
1.820300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.51520000000383E-05 |
| Type1 PRCC-VS-KIRP CIMP |
3.122400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.413600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.971400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.504500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.835200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.584400E-01 |
| Normal-vs-N1 |
6.197200E-01 |
| Normal-vs-N2 |
9.336000E-01 |
| N0-vs-N1 |
8.261600E-01 |
| N0-vs-N2 |
8.729000E-01 |
| N1-vs-N2 |
7.818600E-01 |
|
|
